跳至主要内容
临床试验/ACTRN12609000160235
ACTRN12609000160235已完成不适用

A prospective randomised, controlled clinical trial of the safety and efficacy of Immediate anterior chamber paracentesis in the management of acute primary angle closure

State Key Laboratory of Ophthalmology, Zhongshan Ophthalmic Center,Sun Yat-sen University0 个研究点目标入组 64 人开始时间: 2009年3月27日最近更新:

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
64

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional
分配方式
Randomised controlled trial
主要目的
Treatment
盲法
Blinded (masking used)

入排标准

年龄范围
35 Years 至 81 Years(—)
性别
All

入选标准

  • (1) Intraocular pressure levels of 50 mmhg or more (by Goldman applanation tonometry);(2) ability to give informed consent and to cooperate for slit-lamp anterior chamber paracentesis procedure; (3) Duration of attack, as determined by the onset of symptoms, of 72 hours or less; (4) no medical contraindication to systemic acetazolamide or mannitol treatment; (5) the cornea edema rendering immediate laser peripheral iridotomy unsafe.

排除标准

  • (1) patients who had received antiglaucomatous treatment before being seen by the authors; (2) the eye with acute primary angle closure had previous intraocular surgery; (3) the eye with acute primary angle closurewas patient’s only eye; (4) the eye have other previous ophthalmic disorders that may have a persistent effect on the structure or function of the drainage angle.

研究者

发起方
State Key Laboratory of Ophthalmology, Zhongshan Ophthalmic Center,Sun Yat-sen University

相似试验

Immediate Anterior Chamber Paracentesis for Acute... | 临床试验